Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring strategies in HIV-infected children starting or switching HAART
NL-OMON20993Suspended
- Sponsor
- Paediatric European Network for Treatment of AIDS (PENTA)
- Start
- Oct 2004
- Countries
- 1
01
Overview
Randomised, open-label trial in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Paediatric European Network for Treatment of AIDS (PENTA). Started Oct 2004; status: suspended.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON20993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20993.